Helmut Thomas

Title: Helmut Thomas: Innovator in Gastrointestinal Therapeutics

Introduction

Helmut Thomas is a notable inventor based in Québec, Canada. He has made significant contributions to the field of gastrointestinal therapeutics through his innovative research and development of pharmacological compounds.

Latest Patents

Helmut Thomas holds a patent for "Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders." This invention provides conformationally-defined macrocyclic compounds that bind to and/or are functional modulators of the motilin receptor. These compounds are designed to be therapeutics for a range of gastrointestinal disorders, including diarrhea, irritable bowel syndrome, and inflammatory bowel diseases. The patent highlights the utility of these compounds in treating conditions characterized by poor intestinal absorption and various gastrointestinal disorders.

Career Highlights

Helmut Thomas is associated with Ocera Therapeutics, Inc., where he has been instrumental in advancing research in gastrointestinal treatments. His work focuses on developing effective therapies for patients suffering from gastrointestinal dysmotility disorders.

Collaborations

Throughout his career, Helmut has collaborated with notable colleagues such as Eric Marsault and Graeme Lovat Fraser. These collaborations have contributed to the advancement of research and development in the field of gastrointestinal therapeutics.

Conclusion

Helmut Thomas is a distinguished inventor whose work in developing macrocyclic compounds has the potential to transform the treatment of various gastrointestinal disorders. His contributions to the field are significant and continue to impact therapeutic approaches for patients worldwide.